President Trump signed legislation Wednesday to give terminally ill patients the ability to access experimental drugs that have not won approval from the Food and Drug Administration.
The “right to try” measure will let patients who have exhausted other options access drugs in early stages of FDA review. Trump has frequently noted his support for the idea, most recently during his State of the Union address in January.
“For countless patients, time is not what they have,” the president said. “With the right to try, patients with life-threatening illnesses will finally have access to experimental treatments that could improve or even cure their conditions.”
Read more at USA Today.